Correction to: Is the Availability of Biosimilar Adalimumab Associated with Budget Saving? A Difference-in-Difference Analysis of 14 Countries

Correction to: BioDrugs 10.1007/s40259-023-00636-z

Declarations section: The Funding statement that previously read

Funding This work was supported by the National Research Foundation (NRF-2021R1F1A10502).

should read

Funding This work was supported by the National Research Foundation (NRF-2021R1F1A1050281).

The original article has corrected.